Corbus Pharmaceuticals
CRBP
CRBP
64 hedge funds and large institutions have $3.86M invested in Corbus Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
42% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 12
52% less capital invested
Capital invested by funds: $8.04M → $3.86M (-$4.18M)
Holders
64
Holding in Top 10
–
Calls
$65K
Puts
$31K
Top Buyers
| 1 | +$60K | |
| 2 | +$7.47K | |
| 3 | +$6.68K | |
| 4 |
KCIA
Kingsbury Capital Investment Advisors
Wilmette,
Illinois
|
+$6K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$4.99K |
Top Sellers
| 1 | -$601K | |
| 2 | -$388K | |
| 3 | -$138K | |
| 4 |
IEFM
IQ EQ Fund Management
Dublin 2,
Ireland
|
-$115K |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$77.3K |